PG
AZN icon

Patten Group’s AstraZeneca AZN Stock Holding History

Patten Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.88M Sell
30,089
-2,614
-8% -$504K 1.02% 16
2025
Q4 		$6.01M Sell
32,703
-508
-2% -$89.1K 1.11% 15
2025
Q3 		$5.1M Sell
33,211
-35
-0.1% -$5.3K 0.99% 16
2025
Q2 		$4.65M Buy
33,246
+7,253
+28% +$1.02M 0.98% 18
2025
Q1 		$3.82M Buy
25,993
+346
+1% +$50.1K 0.88% 22
2024
Q4 		$3.36M Sell
25,647
-787
-3% -$110K 0.74% 31
2024
Q3 		$4.12M Sell
26,434
-262
-1% -$42.3K 0.91% 19
2024
Q2 		$4.16M Buy
26,696
+60
+0.2% +$9.03K 0.98% 18
2024
Q1 		$3.61M Sell
26,636
-193
-0.7% -$25.6K 0.89% 24
2023
Q4 		$3.61M Sell
26,829
-447
-2% -$58.1K 0.98% 20
2023
Q3 		$3.69M Sell
27,276
-272
-1% -$37.1K 1.1% 17
2023
Q2 		$3.94M Sell
27,548
-81
-0.3% -$11.9K 0.58% 15
2023
Q1 		$3.84M Sell
27,629
-2
-0% -$269 1.15% 13
2022
Q4 		$3.75M Sell
27,631
-589
-2% -$73.9K 1.18% 14
2022
Q3 		$3.13M Buy
28,220
+170
+0.6% +$21.6K 1.07% 19
2022
Q2 		$3.75M Buy
28,050
+1,163
+4% +$153K 1.2% 12
2022
Q1 		$3.57M Sell
26,887
-1,113
-4% -$133K 1% 17
2021
Q4 		$3.26M Sell
28,000
-1
-0% -$118 0.86% 24
2021
Q3 		$3.36M Sell
28,001
-70
-0.2% -$8.15K 0.99% 18
2021
Q2 		$3.36M Sell
28,071
-668
-2% -$73.3K 0.99% 16
2021
Q1 		$2.86M Sell
28,739
-740
-3% -$74.4K 0.92% 21
2020
Q4 		$2.95M Buy
29,479
+32
+0.1% +$3.39K 0.8% 21
2020
Q3 		$3.23M Buy
29,447
+85
+0.3% +$9.45K 1.26% 12
2020
Q2 		$3.11M Sell
29,362
-558
-2% -$57.6K 1.34% 12
2020
Q1 		$2.67M Sell
29,920
-2,970
-9% -$280K 1.38% 13
2019
Q4 		$3.28M Buy
32,890
+723
+2% +$68.1K 1.22% 15
2019
Q3 		$2.87M Buy
32,167
+981
+3% +$85.1K 1.17% 18
2019
Q2 		$2.58M Buy
31,186
+2,211
+8% +$173K 1.05% 23
2019
Q1 		$2.34M Buy
28,975
+21,324
+279% +$1.68M 1.01% 28
2018
Q4 		$581K Buy
7,651
+2,723
+55% +$213K 0.28% 92
2018
Q3 		$390K Buy
4,928
+57
+1% +$4.31K 0.15% 141
2018
Q2 		$342K Buy
4,871
+4,346
+828% +$313K 0.14% 146
2018
Q1 		$37K Sell
525
-164
-24% -$11.4K 0.02% 352
2017
Q4 		$48K Hold
689
– – 0.02% 341
2017
Q3 		$47K Hold
689
– – 0.02% 329
2017
Q2 		$42K Hold
689
– – 0.02% 339
2017
Q1 		$42K Buy
689
+164
+31% +$9.55K 0.02% 325
2016
Q4 		$28K Sell
525
-600
-53% -$34.1K 0.01% 366
2016
Q3 		$69.4K Hold
1,125
– – 0.03% 275
2016
Q2 		$67.9K Sell
1,125
-75
-6% -$4.36K 0.03% 275
2016
Q1 		$67.6K Hold
1,200
– – 0.03% 269
2015
Q4 		$81.5K Buy
1,200
+135
+13% +$8.85K 0.04% 252
2015
Q3 		$67.8K Hold
1,065
– – 0.03% 255
2015
Q2 		$67.9K Buy
+1,065
New +$72.9K 0.03% 261

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Patten Group's AZN Position: Q1 2026 in Review

Patten Group reduced its AstraZeneca (AZN) stake by 8% in Q1 2026, selling an estimated $504K and leaving 30,089 shares worth $5.88M. The position accounts for 1.02% of the portfolio, ranked #16.

Patten Group first reported a position in AZN in Q2 2015 and has held it in 44 quarters since. The position peaked at $6.01M in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Patten Group held 30,089 shares of AstraZeneca worth $5.88M as of Q1 2026.
  • Patten Group sold 2,614 AstraZeneca shares in Q1 2026, an estimated $504K.
  • AstraZeneca made up 1.02% of Patten Group's portfolio in Q1 2026, its #16 holding.
  • Patten Group first reported a position in AstraZeneca in Q2 2015 and has held it in 44 quarters since.
  • Patten Group's AstraZeneca position peaked at $6.01M in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Patten Group's 13F filing for Q1 2026, filed 24 Apr 2026.